Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognit
about
Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognit
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Feasibility of a randomized si ...... inson's disease without cognit
@en
type
label
Feasibility of a randomized si ...... inson's disease without cognit
@en
prefLabel
Feasibility of a randomized si ...... inson's disease without cognit
@en
P2093
P2860
P1476
Feasibility of a randomized si ...... inson's disease without cognit
@en
P2093
Andrew R Mayes
Julius Sim
Keira Watts
Laura Longshaw
Nicola M J Edelstyn
Simon J Ellis
Thomas A Shepherd
P2860
P2888
P356
10.1186/S40814-017-0154-7
P577
2017-07-06T00:00:00Z
P6179
1090370150